IRIS
SARACINO, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.855
AS - Asia 7.689
EU - Europa 6.706
SA - Sud America 2.012
Continente sconosciuto - Info sul continente non disponibili 1.311
AF - Africa 427
OC - Oceania 16
AN - Antartide 1
Totale 37.017
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.145
SG - Singapore 3.117
IT - Italia 2.680
BR - Brasile 1.508
CN - Cina 1.424
HK - Hong Kong 1.097
DE - Germania 802
VN - Vietnam 642
RU - Federazione Russa 635
SE - Svezia 622
FR - Francia 476
FI - Finlandia 377
GB - Regno Unito 350
BD - Bangladesh 341
CA - Canada 329
IN - India 230
UA - Ucraina 191
AR - Argentina 157
ID - Indonesia 139
CI - Costa d'Avorio 135
NL - Olanda 112
MX - Messico 111
IQ - Iraq 97
ZA - Sudafrica 92
EC - Ecuador 87
PK - Pakistan 83
PL - Polonia 79
TR - Turchia 74
CO - Colombia 67
JP - Giappone 63
VE - Venezuela 62
ES - Italia 61
AT - Austria 55
BE - Belgio 53
SA - Arabia Saudita 50
PH - Filippine 49
PE - Perù 42
CR - Costa Rica 41
LT - Lituania 40
MA - Marocco 38
JM - Giamaica 37
SV - El Salvador 37
IE - Irlanda 36
IL - Israele 34
CL - Cile 33
KE - Kenya 30
MY - Malesia 30
TN - Tunisia 30
NI - Nicaragua 27
JO - Giordania 26
TT - Trinidad e Tobago 26
UZ - Uzbekistan 26
CW - ???statistics.table.value.countryCode.CW??? 24
HN - Honduras 24
CZ - Repubblica Ceca 23
GT - Guatemala 22
PY - Paraguay 22
AE - Emirati Arabi Uniti 16
KZ - Kazakistan 16
CH - Svizzera 15
AZ - Azerbaigian 14
DZ - Algeria 14
ET - Etiopia 14
PS - Palestinian Territory 14
GP - Guadalupe 13
PR - Porto Rico 13
AU - Australia 12
TW - Taiwan 12
UY - Uruguay 12
BO - Bolivia 11
EG - Egitto 11
GR - Grecia 11
HR - Croazia 11
LY - Libia 11
NP - Nepal 11
RS - Serbia 11
SC - Seychelles 11
PA - Panama 10
KW - Kuwait 9
LB - Libano 8
AL - Albania 7
EE - Estonia 7
OM - Oman 7
QA - Qatar 7
BG - Bulgaria 6
BH - Bahrain 6
BY - Bielorussia 6
HU - Ungheria 6
IR - Iran 6
KR - Corea 6
NG - Nigeria 6
RO - Romania 6
SR - Suriname 6
UG - Uganda 6
BZ - Belize 5
DK - Danimarca 5
KG - Kirghizistan 5
PT - Portogallo 5
TH - Thailandia 5
BS - Bahamas 4
Totale 35.637
Salva come PNG Salva come JPEG
Città #
Ashburn 2.181
Singapore 1.743
Fairfield 1.561
San Jose 1.411
Hong Kong 1.091
Woodbridge 1.037
Houston 796
Milan 735
Chandler 709
Seattle 674
Cambridge 534
Dallas 525
Wilmington 524
Council Bluffs 513
Beijing 481
Ann Arbor 476
Nyköping 472
New York 427
Jacksonville 385
Los Angeles 331
Rome 325
Munich 285
Lauterbourg 284
Santa Clara 247
Helsinki 219
Boardman 183
Lawrence 180
Roxbury 179
Ho Chi Minh City 175
Nanjing 173
Columbus 148
São Paulo 147
Abidjan 135
Buffalo 135
Hanoi 130
Bari 129
Falkenstein 125
Des Moines 109
Chicago 96
Jakarta 88
Princeton 88
London 86
Montreal 84
Phoenix 84
Brooklyn 83
Frankfurt am Main 74
Atlanta 70
San Diego 70
Toronto 70
Dong Ket 68
Figino 65
Inglewood 65
Turin 65
Warsaw 63
Tokyo 57
Orem 51
Denver 49
Mexico City 49
Naples 48
North Bergen 48
Moscow 47
Rio de Janeiro 47
Stockholm 47
Brussels 46
San Francisco 46
Johannesburg 42
Turku 42
Hebei 40
Nuremberg 39
Shenyang 36
Chennai 35
Lima 35
San José 35
Curitiba 34
Dublin 34
Palermo 33
Paris 32
Nanchang 31
Brasília 30
Jiaxing 30
Quito 30
Belo Horizonte 29
San Salvador 29
Washington 29
Mumbai 27
Baghdad 26
Guayaquil 26
Managua 26
Tianjin 26
Da Nang 25
Lahore 25
Salt Lake City 25
Amsterdam 24
Bologna 24
Dearborn 24
Haiphong 23
Nairobi 23
Pune 23
Willemstad 23
Boston 22
Totale 22.705
Salva come PNG Salva come JPEG
Nome #
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 441
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals 399
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 377
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 253
First Case of Paraphimosis as a Severe Complication of Monkeypox 247
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 235
Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates 219
Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage 217
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? 211
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 206
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 200
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. 197
An outbreak of HIV-1 BC recombinants in Southern Italy 195
Knowledge, attitudes, and practices about HIV and other sexually transmitted infections among High School students in Southern Italy: A cross-sectional survey 191
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 188
Access to HAART in HIV-Infected Immigrants: A Retrospective Multicenter Italian Study 187
Potential diagnostic properties of chest ultrasound in thoracic tuberculosis—A systematic review 187
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 186
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 185
A 75-year-old woman presenting with nasal vestibulitis 185
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients 182
HIV-1 coreceptor tropism: A syllogistic connection with the veterans aging cohort study index and the CD4/CD8 ratio 180
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study 179
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 178
Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 176
The elderly and direct antiviral agents: Constraint or challenge? 171
Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives 169
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study 167
Survival in HIV-Infected Patients after a Cancer Diagnosis in the cART Era: Results of an Italian Multicenter Study. 166
A 75-year-old woman presenting with nasal vestibulitis 166
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection 165
Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio 164
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 164
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 163
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 163
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 163
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study 162
First Case of Candida Auris Sepsis in Southern Italy: Antifungal Susceptibility and Genomic Characterisation of a Difficult-to-Treat Emerging Yeast 161
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 161
Splenic abscesses as a first manifestation of Crohn's disease: A case report 160
Renal function changes in HCV-infected patients with chronic kidney disease during and after treatment with direct antiviral agents 159
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 158
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection 156
Co-receptor switch during HAART is independent of virological success 156
Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review 156
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). 156
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study. 156
Mortality in migrants living with HIV in western Europe (1997-2013): A collaborative cohort study 155
Incidence of tuberculosis among HIV-Infected patients receiving highly active antiretroviral therapy in Europe and North America 155
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50 cp/mL 154
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 154
Chronic Endometritis and Antimicrobial Resistance: Towards a Multidrug-Resistant Endometritis? An Expert Opinion 153
Prevalence of diabetes mellitus in newly diagnosed pulmonary tuberculosis in Beira, Mozambique 153
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 153
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 153
Improved virological outcome in non-B patients: a possible role for baseline coreceptor tropism 152
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients 151
A Challenging Case of Visceral Leishmaniasis 149
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies 148
V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients 148
The at risk child clinic (ARCC): 3 years of health activities in support of the most vulnerable children in Beira, Mozambique 148
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? 147
Gaining back what is lost: recovering the sense of smell in mild to moderate patients after COVID-19 147
Premature lesions of the carotid vessels in HIV-1 infected patients treated with protease inhibitors 146
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR 146
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study 146
Focused ultrasound to diagnose HIV-associated tuberculosis (FASH) in the extremely resource-limited setting of South Sudan: a cross-sectional study 146
A multidrug-resistant (MDR) HIV type 1 infection in a homosexual man and identified source patient 145
Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients 145
Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections 144
Evolution of antiretroviral prescription and response over a period of 8 years: An Italian multicentre observational prospective cohort study 144
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide 144
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART 143
Hepatic encephalopathy in the course of anti-HCV therapy with paritaprevir/ritonavir, ombitasvir, dasabuvir and ribavirin 142
Are the proposed env mutations actually associated with resistance to maraviroc? 141
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 141
Epidemiological multicentric Italian society of infectious and tropical diseases study on prevalence of tropical diseases in hospitalized immigrants in Italy during 2002 140
Multidisciplinary Approach in the Treatment of Descending Necrotizing Mediastinitis: Twenty-Year Single-Center Experience 140
Monkeypox Virus Infections in Southern Italy: Is There a Risk for Community Spread? 139
Frequent cervicovaginal shedding of HIV-1 in asymptomatic, non-severely immunodeficient women 139
Predictors of therapy failure in newly diagnosed pulmonary tuberculosis cases in Beira, Mozambique. 138
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 138
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic 137
Pulmonary Artery Filling Defects in Covid-19 Patients Revealed Using CT Pulmonary Angiography: A Predictable Complication? 137
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples 136
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 136
Tocilizumab and corticosteroids for COVID-19 treatment in elderly patients 135
Analogies between HPV Behavior in Oral and Vaginal Cavity: Narrative Review on the Current Evidence in the Literature 135
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 135
Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis 134
Impact of a Multistep Bundles Intervention in the Management and Outcome of Gram-Negative Bloodstream Infections: A Single-Center "Proof-of-Concept" Study 134
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 134
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study 134
Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study 133
Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000-2010. 132
HCV and diabetes: Towards a 'sustained' glycaemic improvement after treatment with DAAs? 132
Pathways of care for HIV infected children in Beira, Mozambique: Pre-post intervention study to assess impact of task shifting 132
Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects 131
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program 131
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 130
Totale 16.698
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.333
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022983 0 0 0 0 52 106 81 91 82 93 183 295
2022/20232.087 316 204 150 143 225 293 39 285 311 18 57 46
2023/20241.149 80 216 68 88 111 277 37 42 28 36 40 126
2024/20254.991 125 93 314 142 99 423 542 516 263 344 656 1.474
2025/202614.586 1.611 791 1.141 1.689 1.530 853 1.374 452 1.574 1.378 630 1.563
2026/20274.646 635 842 1.122 1.849 198 0 0 0 0 0 0 0
Totale 37.017